Items where authors include "Ferguson, J."

Article

Nelson, P.A., Bradley, F., Tazzyman, A. et al. (4 more authors) (2025) Beneath the numbers: a qualitative study of the politics of resistance to transparent workforce data reporting. Journal of Health Organization and Management, 39 (9). pp. 419-434. ISSN 1477-7266

Magut, F. orcid.org/0000-0002-9758-2697, Mulwa, S., Gourlay, A. et al. (11 more authors) (2025) What combination of interventions can optimise HIV prevention for adolescent girls and young women? Cohort analysis of DREAMS participation in urban and rural Kenya. PLOS Global Public Health, 5 (10). e0005272. ISSN 2767-3375

Abani, O., Abbas, A., Abbas, F. et al. (7724 more authors) (2025) Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099

Chen, B.S., Seikus, C., Ferguson, J. et al. (4 more authors) (2025) “Adrift From the World”: Exploring the Lived Experiences of Individuals Affected by an Inherited Optic Neuropathy in the United Kingdom—A Qualitative Study. Value in Health. ISSN 1098-3015 (In Press)

Tuschick, E., Ferguson, J., Coulton, S. et al. (8 more authors) (2025) Development of a trial application to assess the effectiveness and cost-effectiveness of adult dRug scrEening and brief interventionS in key hEalth, social care and justice setTings: The RESET PROJECT [version 1; peer review: awaiting peer review]. NIHR Open Research, 5. 49. ISSN 2633-4402

Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099

Kyte, D., Fletcher, B., Horton, M. orcid.org/0000-0002-6675-7335 et al. (12 more authors) (2025) Development, Rasch analysis and validation of the kidney symptom burden questionnaire (KSB-Q). Clinical Kidney Journal, 18 (5). sfaf112. ISSN 2048-8505

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370

Yuille, A. orcid.org/0000-0003-2327-2263, Davies, J., Green, M. et al. (33 more authors) (2024) Moving from features to functions: bridging disciplinary understandings of urban environments to support healthy people and ecosystems. Health & Place, 90. 103368. ISSN 1353-8292

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Coulton, S. orcid.org/0000-0002-7704-3274, Nizalova, O. orcid.org/0000-0002-1704-2632, Pellatt-Higgins, T. orcid.org/0000-0002-2543-461X et al. (9 more authors) (2023) A multicomponent psychosocial intervention to reduce substance use by adolescents involved in the criminal justice system: the RISKIT-CJS RCT. Public Health Research, 11 (3). ISSN 2050-4381

Brunton, L., Tazzyman, A. orcid.org/0000-0003-3441-241X, Ferguson, J. et al. (2 more authors) (2022) The challenges of integrating signposting into general practice: qualitative stakeholder perspectives on care navigation and social prescribing in primary care. BMC Primary Care, 23 (1). 66. ISSN 2731-4553

McMeekin, N., Geue, C., Briggs, A. et al. (7 more authors) (2020) Cost-effectiveness of oral versus intravenous antibiotics (OVIVA) in patients with bone and joint infection : evidence from a non-inferiority trial. Wellcome Open Research, 4. 108.

Holloway, A.S., Ferguson, J., Landale, S. et al. (330 more authors) (2017) Proceedings of the 14th annual conference of INEBRIA. Addiction science & clinical practice, 12 (Suppl 1). ISSN 1940-0632

Hruschka, V., Tangl, S., Ryabenkova, Y. et al. (11 more authors) (2017) Comparison of nanoparticular hydroxyapatite pastes of different particle content and size in a novel scapula defect model. Scientific Reports, 7. 43425. ISSN 2045-2322

Piper, S.C., Ferguson, J., Kay, L. et al. (5 more authors) (2013) The Role of Interleukin-1 and Interleukin-18 in Pro-Inflammatory and Anti-Viral Responses to Rhinovirus in Primary Bronchial Epithelial Cells. PLoS ONE, 8 (5). e63365. ISSN 1932-6203